XML 7 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Document and Entity Information - USD ($)
 12 Months Ended
Dec. 31, 2022
Apr. 06, 2023
Jun. 30, 2022
Cover [Abstract]      
Document Type 10-K/A    
Amendment Flag true    
Amendment Description We are filing this Amendment No. 1 on Form 10-K/A to amend our Annual Report on Form 10-K for the year ended December 31, 2022, as filed with the Securities and Exchange Commission on March 30, 2023 (Original Filing), to include the information required by Part III of Form 10-K. The Part III information was previously omitted from the Original Filing in reliance on General Instruction G(3) to Form 10-K, which permits the information in the above referenced items to be incorporated in the Form 10-K by reference from our definitive proxy statement if such statement is filed no later than 120 days after our fiscal year-end. The information required by Items 10-14 of Part III is no longer being incorporated by reference to the proxy statement relating to our 2023 Annual Meeting of Shareholders. The reference on the cover of the Original Filing to the incorporation by reference to portions of our definitive proxy statement into Part III of the Original Filing is hereby deleted. This Amendment No. 1 is not intended to update any other information presented in the Original Filing. In addition, as required by Rule 12b-15 promulgated under the Securities Exchange Act of 1934, as amended (Exchange Act), new certifications pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 by our principal executive officer and principal financial officer are filed herewith as exhibits to this Amendment No.1. Because no financial statements have been included in this Amendment No. 1 and this Amendment No. 1 does not contain or amend any disclosure with respect to Items 307 and 308 of Regulation S-K, paragraphs 3, 4, and 5 of the certifications have been omitted.    
Document Period End Date Dec. 31, 2022    
Document Fiscal Year Focus 2022    
Document Fiscal Period Focus FY    
Entity Registrant Name Arcadia Biosciences, Inc.    
Entity Central Index Key 0001469443    
Entity Current Reporting Status Yes    
Current Fiscal Year End Date --12-31    
Entity Filer Category Non-accelerated Filer    
Entity Voluntary Filers No    
Entity Well-known Seasoned Issuer No    
Entity Common Stock, Shares Outstanding   857,572  
Entity Public Float     $ 21,027,600
Stock price     $ 40.00
Entity Listing, Par Value Per Share $ 0.001    
Entity Shell Company false    
Entity Emerging Growth Company false    
Entity Small Business true    
Entity File Number 001-37383    
Entity Tax Identification Number 81-0571538    
Entity Address, Address Line One 5950 Sherry Lane    
Entity Address, Address Line Two Suite 215    
Entity Address, City or Town Dallas    
Entity Address, State or Province TX    
Entity Address, Postal Zip Code 75225    
City Area Code 214    
Local Phone Number 974-8921    
Entity Incorporation, State or Country Code DE    
Trading Symbol RKDA    
Title of 12(b) Security Common    
Security Exchange Name NASDAQ    
Entity Interactive Data Current Yes    
Document Annual Report true    
Document Transition Report false    
ICFR Auditor Attestation Flag false    
Documents Incorporated by Reference

None

    
Auditor Firm ID 34    
Auditor Name Deloitte & Touche LLP    
Auditor Location Tempe, AZ, United States